Physician profile
Kelli N Harmon
NPI 1609489004
$4,365.41
in general payments reported to CMS, 2019-2025
32 companies · $966 in 2025
The $966 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $461 · 2022: $869 · 2023: $1,274 · 2024: $795 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,973 · Education: $62.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,972.77 |
| Education | $62.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,013.46 | 2021-2025 | Urolift |
| Abbvie INC. | $365.64 | 2022-2025 | |
| Astellas Pharma US INC | $329.47 | 2021-2024 | Myrbetriq, Veozah |
| Medtronic, INC. | $312.34 | 2022-2025 | Interstim, Intellis Adaptivestim |
| Janssen Biotech, INC. | $296.20 | 2022-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $272.96 | 2021-2025 | |
| Axonics, INC. | $162.15 | 2021-2023 | Axonics |
| Boston Scientific Corporation | $161.18 | 2022-2024 | |
| Calyxo, INC. | $161.12 | 2025 | Cvac Aspiration System |
| Endo USA, INC. | $141.05 | 2024-2025 | Xiaflex, Aveed |
| Allergan, INC. | $127.16 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $112.76 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Immunitybio, INC. | $98.19 | 2025 | |
| Ferring Pharmaceuticals INC. | $97.86 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $94.50 | 2023-2025 | Gemtesa |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $74.41 | 2022-2023 | Jelmyto |
| Sun Pharmaceutical Industries INC. | $72.92 | 2021-2024 | Yonsa |
| Merck Sharp & Dohme LLC | $58.23 | 2023-2025 | Lynparza, Keytruda, Welireg |
| Accord Healthcare, INC. | $48.36 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $46.08 | 2023 | Xiaflex, Aveed |
| Urovant Sciences INC | $44.92 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Dendreon Pharmaceuticals LLC | $31.21 | 2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $30.86 | 2023-2024 | Pylarify |
| Convatec INC. | $30.68 | 2022 | |
| Photocure INC | $28.72 | 2023-2025 | Cysview |
| Genzyme Corporation | $26.58 | 2023 | |
| Blue Earth Diagnostics | $21.04 | 2021 | |
| Tolmar, INC. | $19.95 | 2025 | Jatenzo, Eligard |
| Tolmar Pharmaceuticals, INC. | $18.74 | 2022 | |
| Verity Pharmaceuticals INC. | $16.06 | 2024 | Trelstar |
| Olympus America INC. | $15.55 | 2025 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.